{"id":55175,"date":"2023-03-24T14:04:15","date_gmt":"2023-03-24T13:04:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/"},"modified":"2023-03-24T14:04:15","modified_gmt":"2023-03-24T13:04:15","slug":"tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/","title":{"rendered":"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast"},"content":{"rendered":"<div>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftivichealth.com&amp;esheet=53367185&amp;newsitemid=20230324005120&amp;lan=en-US&amp;anchor=Tivic+Health%26%23174%3B+Systems%2C+Inc.&amp;index=1&amp;md5=eabcb7ae59d058e1d954d243dc95c33f\" rel=\"nofollow noopener\" shape=\"rect\">Tivic Health\u00ae Systems, Inc.<\/a> (\u201cTivic Health\u201d, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the year ended December 31, 2022, via pre-recorded conference call and webcast on Friday, March 31, 2023, at 1:30 pm PT \/ 4:30 pm ET.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/4\/Tivic_Logo_400x400_%281%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg\"><\/a><\/p>\n<p>\n<b>Teleconference Details:<br \/>\n<br \/><\/b>Toll-Free: 888-506-0062<br \/>\n<br \/>International: 973-528-0011<br \/>\n<br \/>Participant Access Code: 990339\n<\/p>\n<p>\n<b>Webcast Link<br \/>\n<br \/><\/b><span class=\"bwuline\"><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.webcaster4.com%2FWebcast%2FPage%2F2865%2F47805&amp;esheet=53367185&amp;newsitemid=20230324005120&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.webcaster4.com%2FWebcast%2FPage%2F2865%2F47805&amp;index=2&amp;md5=9a62d2955574223151380a1d34f437d8\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.webcaster4.com\/Webcast\/Page\/2865\/47805<\/a><\/span>\n<\/p>\n<p>\nShareholders also may submit questions in advance of the earnings call by sending them to the following email address &#8211; <a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;i&#x72;&#x40;&#116;i&#x76;&#x69;&#99;h&#x65;&#x61;&#108;t&#x68;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">ir&#64;&#116;&#105;&#118;&#105;&#x63;&#x68;&#x65;&#x61;&#x6c;&#x74;&#x68;&#46;co&#109;<\/a>. <b>The deadline for submitting questions in advance of the webcast\/conference call is 5:00 PM ET on March 27, 2023<\/b>. Due to time constraints and the nature of the questions please be advised that not all questions submitted can be answered.\n<\/p>\n<p>\n<b>About Tivic Health<\/b>\n<\/p>\n<p>\nTivic Health Systems, Inc. is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers with a choice in the treatment of inflammation and related conditions. For more information visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftivichealth.com&amp;esheet=53367185&amp;newsitemid=20230324005120&amp;lan=en-US&amp;anchor=https%3A%2F%2Ftivichealth.com&amp;index=3&amp;md5=d6e6c711223de466a4ba067dd3524374\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/tivichealth.com<\/a> @TivicHealth.\n<\/p>\n<p>\n<b>Forward-Looking Statements<\/b>\n<\/p>\n<p>\n<i>This press release may contain \u201cforward-looking statements\u201d that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cshould,\u201d \u201cwill\u201d \u201cwould,\u201d or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.\u2019s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.<\/i> <i>Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: market and other conditions; supply chain constraints; macroeconomic factors, including inflation; the risks that the ongoing COVID-19 pandemic may disrupt Tivic\u2019s business more severely than anticipated; and unexpected costs, charges or expenses that reduce Tivic\u2019s capital resources. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Tivic\u2019s actual results to differ from those contained in the forward-looking statements, see Tivic\u2019s filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022, under the heading \u201cRisk Factors\u201d; its Registration Statement on S-1, filed with the SEC on October 26, 2022, under the heading \u201cRisk Factors\u201d; as well as the company\u2019s subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nHanover International, Inc.<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;i&#x72;&#x40;&#116;&#x69;v&#x69;&#x63;&#104;&#x65;a&#x6c;&#x74;&#104;&#x2e;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x72;&#64;&#x74;&#x69;&#118;&#x69;c&#x68;&#x65;&#97;&#x6c;t&#x68;&#x2e;&#99;&#x6f;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Tivic Health\u00ae Systems, Inc. (\u201cTivic Health\u201d, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the year ended December 31, 2022, via pre-recorded conference call and webcast on Friday, March 31, 2023, at 1:30 pm PT \/ 4:30 pm ET. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55175","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Tivic Health\u00ae Systems, Inc. (\u201cTivic Health\u201d, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the year ended December 31, 2022, via pre-recorded conference call and webcast on Friday, March 31, 2023, at 1:30 pm PT \/ 4:30 pm ET. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-24T13:04:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast\",\"datePublished\":\"2023-03-24T13:04:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/\"},\"wordCount\":521,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005120\\\/en\\\/1746764\\\/21\\\/Tivic_Logo_400x400_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/\",\"name\":\"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005120\\\/en\\\/1746764\\\/21\\\/Tivic_Logo_400x400_%281%29.jpg\",\"datePublished\":\"2023-03-24T13:04:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005120\\\/en\\\/1746764\\\/21\\\/Tivic_Logo_400x400_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005120\\\/en\\\/1746764\\\/21\\\/Tivic_Logo_400x400_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/","og_locale":"en_US","og_type":"article","og_title":"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast - Pharma Trend","og_description":"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Tivic Health\u00ae Systems, Inc. (\u201cTivic Health\u201d, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the year ended December 31, 2022, via pre-recorded conference call and webcast on Friday, March 31, 2023, at 1:30 pm PT \/ 4:30 pm ET. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-24T13:04:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast","datePublished":"2023-03-24T13:04:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/"},"wordCount":521,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/","url":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/","name":"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg","datePublished":"2023-03-24T13:04:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230324005120\/en\/1746764\/21\/Tivic_Logo_400x400_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-to-report-fiscal-year-2022-financial-results-on-march-31st-via-conference-call-and-webcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55175"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55175\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}